Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries

• Main Authors: Stolbrink, M., Chinouya, M. J., Jayasooriya, S., Nightingale, R., Evans-Hill, L., Allan, K., Allen, H., Balen, J., Beacon, T., Bissell, K., Chakaya, J., Chiang, C-y., Cohen, M., Devereux, G., El Sony, A., Halpin, D. M. G., Hurst, J. R., Kiprop, C., Lawson, A., Mace, C., Makhanu, A., Makokha, P., Masekela, R., Meme, H., Khoo, Ee Ming, Nantanda, R., Pasternak, S., Perrin, C., Reddel, H., Rylance, S., Schweikert, P., Were, C., Williams, S., Winders, T., Yorgancioglu, A., Marks, G. B., Mortimer, K.
• Format: Article
• Published: INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D) 2022
• Subjects: R Medicine
• Online Access: http://eprints.um.edu.my/46215/; https://doi.org/10.5588/ijtld.22.0270

BACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low-and middle-income countries (LMICs), causing avoidable morbidity and mortality. The Inter-national Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this...